Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-64
Closed -$3.42K 731
2023
Q1
$3.42K Sell
64
-414
-87% -$24K ﹤0.01% 1314
2022
Q4
$25.6K Buy
478
+187
+64% +$9.65K ﹤0.01% 786
2022
Q3
$13K Buy
291
+280
+2,545% +$15.2K ﹤0.01% 924
2022
Q2
$1K Sell
11
-71
-87% -$4.58K ﹤0.01% 1243
2022
Q1
$6K Sell
82
-57
-41% -$4.06K ﹤0.01% 977
2021
Q4
$11K Buy
139
+112
+415% +$9.37K ﹤0.01% 836
2021
Q3
$2K Buy
27
+10
+59% +$804 ﹤0.01% 1128
2021
Q2
$1K Buy
17
+3
+21% +$230 ﹤0.01% 1142
2021
Q1
$1K Buy
+14
New +$1.03K ﹤0.01% 1144

Other funds holding ENOV

Ellevest Inc's ENOV Position: Q2 2023 in Review

Ellevest Inc sold out of Enovis (ENOV) in Q2 2023, closing a stake of 64 shares — an estimated $3.42K sold.

Ellevest Inc first reported a position in ENOV in Q1 2021 and held it in 9 quarters. The position peaked at $25.6K in Q4 2022. 261 funds tracked by Wall St. Rank hold ENOV as of Q2 2023.

  • Ellevest Inc reported no remaining Enovis position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 64 Enovis shares in Q2 2023, an estimated $3.42K.
  • Ellevest Inc first reported a position in Enovis in Q1 2021 and held it in 9 quarters.
  • Ellevest Inc's Enovis position peaked at $25.6K in Q4 2022.
  • 261 funds tracked by Wall St. Rank held Enovis as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.